Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 46.

Vokinger, Kerstin Noëlle; Mühlematter, Urs Jakob; Becker, Anton S; Boss, Andreas; Reutter, Mark A; Szucs, Thomas D (2017). Artificial Intelligence und Machine Learning in der Medizin: eine medizinische und rechtliche Würdigung am Beispiel der Radiologie. Jusletter, (28.08.2017):online.

Blank, Patricia R; Ademi, Zanfina; Lu, Xiaoyan; Szucs, Thomas D; Schwenkglenks, Matthias (2017). Herpes zoster vaccine: A health economic evaluation for Switzerland. Human Vaccines & Immunotherapeutics, 13(7):1495-1504.

Gutzwiller, Florian S; Pfeil, Alena M; Ademi, Zanfina; Blank, Patricia R; Braunhofer, Peter G; Szucs, Thomas D; Schwenkglenks, Matthias (2015). Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland. Pharmacoeconomics, 33(12):1311-1324.

Vulsteke, Christof; Pfeil, Alena M; Maggen, Charlotte; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2015). Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Research and Treatment, 152(1):67-76.

Blank, Patricia R; Filipits, Martin; Dubsky, Peter; Gutzwiller, Florian; Lux, Michael P; Brase, Jan C; Weber, Karsten E; Rudas, Margaretha; Greil, Richard; Loibl, Sibylle; Szucs, Thomas D; Kronenwett, Ralf; Schwenkglenks, Matthias; Gnant, Michael (2015). Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients. Pharmacoeconomics, 33(2):179-190.

Pfeil, Alena M; Imfeld, Patrick; Pettengell, Ruth; Jick, Susan S; Szucs, Thomas D; Meier, Christoph R; Schwenkglenks, Matthias (2015). Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD). Annals of Hematology, 94(3):421-429.

Vulsteke, Christof; Pfeil, Alena M; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Peeters, Marc; van Dam, Peter; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2014). Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast Cancer Research and Treatment, 147(3):557-70.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri M; Szucs, Thomas D; Schwenkglenks, Matthias; Pestalozzi, Bernhard C (2014). Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09). BMC Cancer, 14(1):306.

Groux, Philippe; Anchisi, Sandro; Szucs, Thomas D (2014). Are cancer patients willing to travel more or further away for a slightly more efficient therapy? Cancer and Clinical Oncology, 3(1):36-42.

Groux, Philippe; Anchisi, Sandro; Szucs, Thomas D (2014). How do gender, age and travel time impact on the need for social support of patients to have access to cancer treatment? Cancer and Clinical Oncology, 3(2):27-35.

Pfeil, Alena M; Vulsteke, Christof; Paridaens, Robert; Dieudonné, Anne-Sophie; Pettengell, Ruth; Hatse, Sigrid; Neven, Patrick; Lambrechts, Diether; Szucs, Thomas D; Schwenkglenks, Matthias; Wildiers, Hans (2014). Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC Cancer, 14:201.

Snozzi, Philippe; Blank, Patricia R; Szucs, Thomas D (2014). Stroke in Switzerland: Social determinants of treatment access and cost of illness. Journal of Stroke and Cerebrovascular Diseases, 23(5):926-932.

Szucs, Thomas D; Puri, Daniele; Blank, Patricia R (2014). The use of the EVITA algorithm for clinical assessment of novel agents used in prostate cancer, metastatic melanoma, and systemic lupus erythematosus. European Journal of Clinical Pharmacology, 70(8):983-990.

Gutzwiller, Florian S; Pfeil, Alena M; Comin-Colet, Josep; Ponikowski, Piotr; Filippatos, Gerasimos; Mori, Claudio; Braunhofer, Peter G; Szucs, Thomas D; Schwenkglenks, Matthias; Anker, Stefan D (2013). Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis. International Journal of Cardiology, 168(4):3878-3883.

Groux, Philippe; Szucs, Thomas D (2013). Geographic disparities in access to cancer care: Do patients in outlying areas talk about their access problems to their general practitioners and medical oncologists and how does that impact on the choice of chemotherapy? European Journal of Cancer Care, 22(6):746-753.

Beck, Konstantin (2013). Politik und Wissenschaft im Gesundheitswesen - Kollaboration oder Power Play? In: Szucs, Thomas D; Künzi, Max. Brennpunkt Gesundheitssystem : 10 Jahre Schweizerischer Kongress für Gesundheitsökonomie und Gesundheitswissenschaften. Bern: SGGP, 69-72.

Blank, Patricia R; Schwenkglenks, Matthias; Sardos, Christelle Saint; Patris, Julien; Szucs, Thomas D (2013). Population access to new vaccines in European countries. Vaccine, 31(27):2862-2867.

Blank, Patricia R; Szucs, Thomas D (2013). Socio-economic impact. In: Van-Tam, Jonathan; Sellwood, Chloe. Pandemic influenza. Wallingford, Oxfordshire: CABI.

Schwenkglenks, Matthias (2013). Stabilisierung der Gesundheitskosten in der Schweiz - ein Zwischenstand. In: Szucs, Thomas D; Künzi, Max. Brennpunkt Gesundheitssystem : 10 Jahre Schweizerischer Kongress für Gesundheitsökonomie und Gesundheitwissenschaften. Bern: Schweizerische Gesellschaft für Gesundheitspolitik, 33-36.

Tomonaga, Yuki; Haettenschwiler, Josef; Hatzinger, Martin; Holsboer-Trachsler, Edith; Rufer, Michael; Hepp, Urs; Szucs, Thomas D (2013). The economic burden of depression in Switzerland. Pharmacoeconomics, 31(3):237-250.

Blank, Patricia R; Bonnelye, Genevieve; Ducastel, Aurore; Szucs, Thomas D (2012). Attitudes of the General Public and General Practitioners in Five Countries towards Pandemic and Seasonal Influenza Vaccines during Season 2009/2010. PLoS ONE, 7(10):e45450.

Blank, Patricia R; Szucs, Thomas D (2012). Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland. Vaccine, 30(28):4267-4275.

Schwenkglenks, Matthias; Toward, Toby J; Plent, Stephanie; Szucs, Thomas D; Blackman, Daniel J; Baumbach, Andreas (2012). Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction. Heart (British Cardiac Society), 98(7):544-551.

Matter-Walstra, Klazien; Joerger, Markus; Kühnel, Ursula; Szucs, Thomas D; Pestalozzi, Bernhard; Schwenkglenks, Matthias (2012). Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the Swiss health care system. Value in Health, 15(1):65-71.

Gutzwiller, Florian S; Schwenkglenks, Matthias; Blank, Patricia R; Braunhofer, Peter G; Mori, Claudio; Szucs, Thomas D; Ponikowski, Piotr; Anker, Stefan D (2012). Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK. European Journal of Heart Failure, 14(7):782-790.

Blank, Patricia R; Szucs, Thomas D (2012). Kosten-Nutzwert-Analyse von verschiedenen diagnostischen und therapeutischen Optionen : das Beispiel Brustkrebs. In: Bürki, Nicole; Hürlimann, Denise C; Baumann-Hölzle, Ruth; Müller, Hansjakob. Familiärer Brustkrebs : Diagnose, Beratung, Therapie und Langzeitbetreuung. Zürich: Schulthess, 205-214.

Gutzwiller, Florian; Biller-Andorno, Nikola; Harnacke, Caroline; Bollhalder, Lea; Szucs, Thomas D; Gutzwiller, Felix; Schwenkglenks, Matthias (2012). Methoden zur Bestimmung von Nutzen bzw. Wert medizinischer Leistungen und ihre ethischen Implikationen. Bern: Akademien der Wissenschaften Schweiz.

Gutzwiller, Florian; Biller-Andorno, Nikola; Harnacke, Caroline; Bollhalder, Lea; Szucs, Thomas D; Gutzwiller, Felix; Schwenkglenks, Matthias (2012). Methoden zur Bestimmung von Nutzen bzw. Wert medizinischer Leistungen und ihre ethischen Implikationen. Gesundheits- und Sozialpolitik, 66(2):30-36.

Rüegg, Christian P; Graf, Nicole; Mühleisen, Beda; Szucs, Thomas D; French, Lars E; Surber, Christian; Hofbauer, Günther F L (2012). Squamous cell carcinoma of the skin induces considerable sustained cost of care in organ transplant recipients. Journal of the American Academy of Dermatology, 67(6):1242-1249.

Blank, Patricia; Schwenkglenks, Matthias; Szucs, Thomas D (2012). The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Human Vaccines & Immunotherapeutics, 8(3):328-335.

Tomonaga, Yuki; Gutzwiller, Felix; Lüscher, Thomas F; Riesen, Walter F; Hug, Markus; Diemand, Albert; Schwenkglenks, Matthias; Szucs, Thomas D (2011). Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care:a cluster-randomised controlled trial. BMC Family Practice, 12:12.

Szucs, Thomas D; Kressig, Reto W; Papageorgiou, Manto; Kempf, Werner; Michel, Jean-Pierre; Fendl, Anton; Bresse, Xavier (2011). Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland. Human Vaccines, 7(7):749-756.

Pfeil, A; Mütsch, Margot; Hatz, Christoph; Szucs, Thomas D (2010). A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations. BMC Public Health, 10:402.

Szucs, Thomas D; Dedes, Konstantin J (2009). Is cancer prevention ever going to be profitable? In: Senn, H J; Kapp, U; Ott, F. Cancer Prevention II. Berlin: Springer, 41-47.

Meier, Christiane; Stähli, Roland; Szucs, Thomas D (2006). Ökonomische Nutzen und Kosten populationsbezogener Prävention und Gesundheitsförderung. Gesundheitsökonomie & Qualitätsmanagement, 11(3):168-175.

Lowy, A; Page, Julie; Jaccard, R; Ledergerber, B; Somaini, Bertino; Weber, R; Szucs, Thomas D (2005). Costs of treatment of Swiss patients with HIV on antiretroviral therapy in hospital-based and general practice-based care: a prospective cohort study. AIDS Care, 17(6):698-710.

Szucs, Thomas D; Kaiser, W E; Mahler, F; Gutzwiller, Felix (2005). Thromboembolic Prophylaxis with Fondaparinux in Major Orthopaedic Surgery: Outcomes and Costs. Heart Drug, 5(3):121-130.

Szucs, Thomas D; Burnier, Michel; Erne, Paul (2004). Cost-Effectiveness of Losartan Versus Atenolol in Treating Hypertension - An Analysis of the LIFE Study from a Swiss Perspective. Cardiovascular Drugs and Therapy, 18(5):391-397.

Szucs, Thomas D; Schwenkglenks, Matthias; Cathomas, G; Geschwindner, H; Gutzwiller, Felix (2004). Früherfassung des Bronchuskarzinoms – Chancen und Risiken. Schweizerische Ärztezeitung, 85(16):840-843.

Szucs, Thomas D; Ruef, Christian; Müller, Daniela; Sokolovic, E; Beeler, Iris; Ostermayer, Wolfjgang (2001). The Economic Impact of Influenza in a University Hospital Setting. Infection Control and Hospital Epidemiology, 22(08):472-474.

Gutzwiller, Felix; Szucs, Thomas D (2001). Diabetes - Epidemie des 21. Jahrhunderts? Mitteilungen der Lebensversicherer an die Schweizer Ärzteschaft, 2001(2):4-8.

Szucs, Thomas D; Bertel, Osmund; Darioli, Roger; Gutzwiller, Felix; Mordasini, Rubino (2000). Pharmakoökonomische Bewertung von Pravastatin in der koronaren Sekundärprävention bei Patienten mit Myokardinfarkt oder instabiler Angina Pectoris : eine Analyse auf der Grundlage der LIPID-Studie. Praxis, 89(18):745-52.

Szucs, Thomas D; Bertel, Osmund; Darioli, Roger; Gutzwiller, Felix; Mordasini, Rubino (1999). Evaluation pharmaco-économique de la pravastatine dans la prévention coronaire secondaire chez les patients victimes d'infarctus du myocarde ou d'angine de poitrine instable. Médecine et Hygiène, 57:1667-1673.

Szucs, Thomas D; Gutzwiller, Felix (1998). Grundlagen der Kosten-Nutzen-Analyse bei der Langzeitbehandlung von Risikofaktoren. Swiss Medical Weekly, 128(49):1958-64.

Szucs, Thomas D; Gutzwiller, Felix (1998). Medizinisch-ökonomische Aspekte des Praxislabors. Schweizerische Ärztezeitung (SÄZ), 79(45):2296-2297.

Szucs, Thomas D; Lüscher, T F; Gutzwiller, Felix (1997). Einfluss der medikamentösen Cholesterinsenkung auf den Ressourcenverbrauch im Gesundheitswesen - Bedeutung der Scandinavian Simvastatin Survival Study (4-S-Studie) für die Kostenreduktion unter Schweizer Verhältnissen. Swiss Medical Weekly, 127(44):1819-1823.

This list was generated on Sun Nov 18 15:13:29 2018 CET.